83 related articles for article (PubMed ID: 9859810)
1. Phenotypic heterogeneity of PHA-activated CD69+ lymphocytes: the expression of APO-1/FAS antigen (CD95) and perforins identifies different functional subsets.
Rutella S; Rumi C; Lucia MB; Cauda R; Leone G
Eur J Histochem; 1997; 41 Suppl 2():117-8. PubMed ID: 9859810
[No Abstract] [Full Text] [Related]
2. Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells.
Rutella S; Rumi C; Lucia MB; Barberi T; Puggioni PL; Lai M; Romano A; Cauda R; Leone G
Cytometry; 1999 Jun; 38(3):95-101. PubMed ID: 10397327
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
4. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791
[TBL] [Abstract][Full Text] [Related]
5. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
6. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
7. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
Büssing A; Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
[TBL] [Abstract][Full Text] [Related]
8. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
[TBL] [Abstract][Full Text] [Related]
10. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.
Borges O; Borchard G; de Sousa A; Junginger HE; Cordeiro-da-Silva A
Int J Pharm; 2007 Jun; 337(1-2):254-64. PubMed ID: 17317051
[TBL] [Abstract][Full Text] [Related]
11. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
[TBL] [Abstract][Full Text] [Related]
12. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cell surface antigens on subsets of CD4+ and CD8+ T cells.
Olson DP; Dombkowski DM; Kelliher AS; Pontillo C; Anderson DC; Preffer FI
Med Sci Monit; 2004 Sep; 10(9):BR339-45. PubMed ID: 15328479
[TBL] [Abstract][Full Text] [Related]
14. The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans.
Brush J; Mendenhall E; Guggenheim A; Chan T; Connelly E; Soumyanath A; Buresh R; Barrett R; Zwickey H
Phytother Res; 2006 Aug; 20(8):687-95. PubMed ID: 16807880
[TBL] [Abstract][Full Text] [Related]
15. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery.
Cottam DR; Schaefer PA; Shaftan GW; Angus LD
Obes Surg; 2003 Feb; 13(1):49-57. PubMed ID: 12630613
[TBL] [Abstract][Full Text] [Related]
17. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients.
Salomao R; Brunialti MK; Kallás EG; Martins PS; Rigato O; Freudenberg M
J Endotoxin Res; 2002; 8(5):371-9. PubMed ID: 12537696
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
Niiya H; Sakai I; Lei J; Azuma T; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Exp Hematol; 2005 Jul; 33(7):811-8. PubMed ID: 15963857
[TBL] [Abstract][Full Text] [Related]
20. Perforin expression in peripheral blood lymphocytes and skin-infiltrating cells in patients with lichen planus.
Prpić Massari L; Kastelan M; Gruber F; Laskarin G; Sotosek Tokmadzić V; Strbo N; Zamolo G; Zauhar G; Rukavina D
Br J Dermatol; 2004 Aug; 151(2):433-9. PubMed ID: 15327551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
